Skip to main content

Articles

FDA Approved Xdemvy, First Treatment for Demodex Blepharitis

FDA Accelerated the Approval of Veopoz, First Drug for the Treatment of Patients With CHAPLE Disease

FDA Accelerated the Approval of Sohonos, First Drug for the Treatment of Fibrodysplasia Ossificans Progressiva

FDA Accelerated the Approval of Akeega, First and Only Dual-Action Tablet for Metastatic Prostate Cancer With BRCA Mutation

FDA Granted Accelerated Approval to Elrexfio, a Bispecific BCMA-Directed CD3 T-Cell Engager, for Relapsed or Refractory MM

Hepzato Kit FDA Approved as a Liver-Directed Treatment for Uveal Melanoma With Hepatic Metastases

Gavreto Received Regular FDA Approval for Patients With Non–Small Cell Lung Cancer and RET Gene Fusion

Original Research, Practice Management

Employer Disability and Workers’ Compensation Trends for Their Employees With Ophthalmic Conditions in the United States

Richard A. Brook, MS, MBA; Nathan L. Kleinman, PhD; Ian A. Beren, BS

Disparities in Cancer Care, Urothelial Cancer, Oncology

Addressing Health Equity in Bladder Cancer Care

William King

Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer

Page 9 of 244
Results 81 - 90 of 2434